Preeclampsia as a maternal vascular disease

Harefuah

Volumn 146, Issue 9, 2007, Pages 707-712

  Amash, Alaa ^a   Huleihel, Mahmoud ^a   Sheiner, Eyal ^a   Sapir, Olga ^a   Holcberg, Gershon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cytokines; Endothelium; Preeclampsia; Vasoconstrictor; Vasodilator agents

Indexed keywords

CYTOKINE; NITRIC OXIDE; VASCULOTROPIN A;

FEMALE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY; REVIEW; VASCULAR DISEASE;

CYTOKINES; FEMALE; HUMANS; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38449100270     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Lain KY & Roberts JM, Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA, 2002; 287: 3183-6.
2. Masse J, Giguere Y, Kharfi A & al, Pathophysiology and maternal biologic markers of preeclampsia. Endocrine, 2002; 19: 113-25.
3. Waite LL, Atwood AK & Taylor RN, Preeclampsia, an implantation disorder. Rev Endocr Metab Disord, 2002; 3: 151-8.
4. Redman CW & Sargent IL, Latest advances in understanding preeclampsia. Science, 2005; 308: 1592-4.
5. Duckitt K & Harrington D, Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ, 2005; 330: 549-50.
6. Red-Horse K, Zhou Y, Genbacev O & al, Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest, 2004; 114: 744-54.
7. Pijnenborg R, Anthony J, Davey DA & al, Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol, 1991; 98: 648-55.
8. Roberts JM, Taylor RN & Goldfien A, Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens, 1991; 4: 700-8.
9. Roberts JM & Cooper DW, Pathogenesis and genetics of preeclampsia. Lancet, 2001; 357: 53-6.
10. Levine RJ & Karumanchi SA, Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol, 2005; 48: 372-86.
11. Friedman SA, Schiff E, Emeis JJ & al, Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol, 1995; 172: 202-3.
12. Boura AL, Walters WA, Read MA, & al, Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol, 1994; 21: 737-48.
13. Walsh SW, Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids, 2004; 70: 223-32.
14. Rosselli M, Keller PJ & Dubey RK, Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update, 1998; 4: 3-24.
15. Myatt L, Brockman DE, Eis AL & al, Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta, 1993; 14: 487-95.
16. Sladek SM, Magness RR & Conrad KP, Nitric oxide and pregnancy. Am J Physiol, 1997; 272: R441-63.
17. Molnar M, Suto T, Toth T & al, Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol, 1994; 170: 1458-66.
18. Seligman SP, Buyon JP, Clancy RM & al, The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol, 1994; 171: 944-8.
19. Wang Y, Gu Y, Zhang Y & al, Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol, 2004; 190: 817-24.
20. Rowe J, Campbell S & Gallery ED, Nitric oxide production by decidual endothelial cells is not reduced in preeclampsia. Hypertens Pregnancy, 2003; 22: 63-75.
21. nd ed. New York, NY: Raven Press; 1995, pp 2407-2426.
22. Ajne G, Wolff K, Fyhrquist F & al, Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia. Hypertens Pregnancy, 2003; 22: 215-24.
23. Das UN, Is angiotensin-II an endogenous pro-inflammatory molecule? Med Sci Monit, 2005; 11: RA155-162.
24. Donoghue M, Hsieh F, Baronas E & al, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res, 2000; 87: E1-9.
25. Taira H, Mizutani S, Narita O & al, Angiotensin I-converting enzyme in human placenta. Placenta, 1985; 6: 543-9.
26. Itakura A & Mizutani S, Involvement of placental peptidases associated with renin-angiotensin systems in preeclampsia. Biochim Biophys Acta, 2005; 1751: 68-72.
27. AbdAlla S, Lother H, el Massiery A & al, Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med, 2001; 7: 1003-9.
28. Tischer E, Mitchell R, Hartman T & al, The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem, 1991; 266: 11947-54.
29. Semenza GL, Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J Clin Invest, 2001; 108: 39-40.
30. Hunter L, Aitkenhead M, Caldwell C & al, Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension, 2000; 36.
31. Levine RJ & Karumanchi SA, Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol, 2005; 48: 372-86.
32. Livingston JC, Chin R, Haddad B & al, Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol, 2000; 183: 1554-7.
33. Koga K, Osuga Y, Yoshino O & al, Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab, 2003; 88: 2348-51.
34. Tsatsaris V, Goffin F, Munaut C & al, Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab, 2003; 88: 5555-63.
35. Kharfi A, Giguere Y, Sapin V & al, Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin Biochem, 2003; 36: 323-31.
36. Marzi M, Vigano A, Trabattoni D & al, Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol, 1996; 106: 127-33.
37. Bowen JM, Chamley L, Keelan JA & al, Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta, 2002; 23: 257-73.
38. Benyo DF, Miles TM & Conrad KP, Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab, 1997; 82: 1582-8.